statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	7.066
EU - Europa	3.002
AS - Asia	2.905
SA - Sud America	380
AF - Africa	85
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	6
Totale	13.457

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.943
IT - Italia	1.577
SG - Singapore	1.093
CN - Cina	589
HK - Hong Kong	430
VN - Vietnam	405
BR - Brasile	307
UA - Ucraina	286
IE - Irlanda	195
DE - Germania	177
SE - Svezia	156
GB - Regno Unito	147
FR - Francia	130
BD - Bangladesh	119
RU - Federazione Russa	105
TR - Turchia	81
FI - Finlandia	65
MX - Messico	57
CA - Canada	52
AT - Austria	49
JP - Giappone	34
AR - Argentina	33
IN - India	31
NG - Nigeria	27
IQ - Iraq	23
ZA - Sudafrica	23
ES - Italia	22
NL - Olanda	19
PL - Polonia	17
ID - Indonesia	16
CL - Cile	14
PK - Pakistan	14
AU - Australia	12
CZ - Repubblica Ceca	12
MY - Malesia	11
SA - Arabia Saudita	9
IR - Iran	7
LT - Lituania	7
RO - Romania	7
EC - Ecuador	6
AE - Emirati Arabi Uniti	5
EG - Egitto	5
EU - Europa	5
PH - Filippine	5
SK - Slovacchia (Repubblica Slovacca)	5
VE - Venezuela	5
JO - Giordania	4
KE - Kenya	4
KZ - Kazakistan	4
MA - Marocco	4
MD - Moldavia	4
OM - Oman	4
PT - Portogallo	4
PY - Paraguay	4
TN - Tunisia	4
UY - Uruguay	4
AL - Albania	3
BE - Belgio	3
DZ - Algeria	3
HN - Honduras	3
HU - Ungheria	3
NP - Nepal	3
PE - Perù	3
SN - Senegal	3
TT - Trinidad e Tobago	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
BH - Bahrain	2
BO - Bolivia	2
CH - Svizzera	2
CO - Colombia	2
DK - Danimarca	2
GN - Guinea	2
KH - Cambogia	2
LK - Sri Lanka	2
ZM - Zambia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
BN - Brunei Darussalam	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CU - Cuba	1
CY - Cipro	1
ET - Etiopia	1
GA - Gabon	1
GD - Grenada	1
GE - Georgia	1
GR - Grecia	1
GT - Guatemala	1
JM - Giamaica	1
KG - Kirghizistan	1
LY - Libia	1
ML - Mali	1
MU - Mauritius	1
MZ - Mozambico	1
NI - Nicaragua	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
Totale	13.451

Salva come PNG Salva come JPEG

Città	#
Milan	1.038
Fairfield	746
Ashburn	700
San Jose	602
Singapore	581
Hong Kong	425
Woodbridge	351
Chandler	337
Houston	309
Seattle	287
Wilmington	286
Cambridge	279
Jacksonville	271
Dallas	203
Beijing	192
Dublin	190
Princeton	182
The Dalles	164
Council Bluffs	144
Ann Arbor	134
Chicago	124
Boardman	123
New York	122
Lauterbourg	112
Nyköping	99
Dearborn	93
Rome	93
Dong Ket	89
Ho Chi Minh City	88
Los Angeles	82
San Diego	77
London	67
Izmir	62
Hanoi	51
Helsinki	51
Santa Clara	47
Ogden	45
Munich	44
Mexico City	43
São Paulo	39
Nuremberg	30
Vienna	30
Abuja	27
Salt Lake City	25
Tokyo	25
Orem	23
Frankfurt am Main	22
San Francisco	22
Redmond	21
Washington	20
San Genesio Ed Uniti	19
Como	17
Phoenix	17
Atlanta	16
Guangzhou	15
Tampa	15
Toronto	15
Brooklyn	14
Norwalk	14
Warsaw	14
Buffalo	13
Haiphong	13
Hangzhou	13
Montreal	13
Shanghai	13
Elk Grove Village	12
Hefei	12
Belo Horizonte	11
Brno	11
Chennai	11
Johannesburg	11
Kunming	11
Varese	11
Baghdad	10
Pavia	9
Stockholm	9
Cedar Knolls	8
Columbus	8
Dhaka	8
Kilburn	8
Lancaster	8
Magnago	8
Rio de Janeiro	8
Biên Hòa	7
Denver	7
Falkenstein	7
Jakarta	7
Kuala Lumpur	7
Manchester	7
Miami	7
Monza	7
Naples	7
Amsterdam	6
Boston	6
Cape Town	6
Charlotte	6
Da Nang	6
Lappeenranta	6
Miano	6
Redwood City	6
Totale	9.723

Salva come PNG Salva come JPEG

Nome	#
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	330
Adverse Reactions to Food: Allergies and Intolerances	263
Classifying new anti-tuberculosis drugs: rationale and future perspectives	249
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	231
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	212
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	202
When kidneys and lungs suffer together	198
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	192
Tuberculosis elimination: Where are we now?	177
Cardiovascular function in pulmonary emphysema	177
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	176
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	175
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	173
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	173
Intestine: Organ or Apparatus?	173
Is bronchodilator the correct treatment for COPD subjects before EBUS?	169
Classification of Malabsorption Syndromes	167
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	164
Ambulatory oxygen in interstitial lung disease	164
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	160
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	158
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	157
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	155
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	153
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	153
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	151
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	150
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	146
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	146
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	142
World TB Day 2017: Strengthening the fight against TB	142
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	141
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	141
The 5-repetition sit-to-stand test as an outcome measure for pulmonary rehabilitation in subjects with asthma	141
Electrocardiographic features of patients with COVID-19 pneumonia	139
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	139
Evolution of programmatic definitions used intuberculosis prevention and care	138
Fecal calprotectin concentrations in alcoholic patients: A longitudinal study	136
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	135
Minimal clinically important difference of the 6-min walking test in patients with asthma	133
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	132
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	131
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	128
Pulmonary Rehabilitation and Asthma	127
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	126
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	122
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	121
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	118
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	117
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	116
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	115
Severity of COVID-19: The importance of being hypertensive	107
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	107
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	107
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	107
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	106
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	105
Chronic cough in adults	104
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	100
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy	100
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	99
Pulmonary rehabilitation in patients recovering from COVID-19	98
SARS-CoV-2 vaccines: Lights and shadows	98
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	97
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	96
Tuberculosis and COVID-19 co-infection: description of the global cohort	96
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	95
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	90
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	90
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	90
Post tuberculosis treatment infectious complications	89
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	89
Post-TB disease: a new topic for investigation-and why it matters	88
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	88
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	88
Severe asthma: One disease and multiple definitions	85
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	84
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	84
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	83
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	82
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	79
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	78
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	78
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	78
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	77
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	77
Alpha-1 deficiency in severe asthma patients	76
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease	75
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	75
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	75
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease	73
An overview of Cochrane systematic reviews for pulmonary rehabilitation interventions in people with chronic obstructive pulmonary disease: a mapping synthesis	72
Management of chronic refractory cough in adults	72
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	69
Tuberculosis in the time of COVID-19: quality of life and digital innovation	68
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	68
Current developments and future directions in COPD	68
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	68
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	67
Heart rate recovery in adult individuals with asthma	66
Totale	12.385

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	71.365
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	71.365

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	291	0	0	0	0	0	0	0	0	0	0	0	291
2021/2022	970	147	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.808	248	259	245	301	374	154	72	18	75	39	6	17
2024/2025	1.880	20	25	281	50	74	140	67	76	237	275	176	459
2025/2026	4.484	314	272	247	485	312	221	1.020	288	495	293	287	250
Totale													13.812